Industries > Pharmaceutical/Biotech | SupplyChainBrain
Webinars
Podcasts
Videos
Events
Subscribe
Sign In
Logistics
Air Cargo
All Logistics
Facility Location Planning
Freight Forwarding/Customs Brokerage
Global Gateways
Global Logistics
Last Mile Delivery
Logistics Outsourcing
LTL/Truckload Services
Ocean Transportation
Parcel & Express
Rail & Intermodal
Reverse Logistics
Service Parts Management
Transportation & Distribution
Technology
All Technology
Artificial Intelligence
Cloud & On-Demand Systems
Data Management (Big Data/IoT/Blockchain)
ERP & Enterprise Systems
Forecasting & Demand Planning
Global Trade Management
Inventory Planning/Optimization
Product Lifecycle Management
Robotics
Sales & Operations Planning
SC Finance & Revenue Management
SC Planning & Optimization
Supply Chain Visibility
Transportation Management
General SCM
Business Strategy Alignment
Customer Relationship Management
Education & Professional Development
Global Supply Chain Management
Global Trade & Economics
Green Energy
HR & Labor Management
Quality & Metrics
Regulation & Compliance
Sourcing/Procurement/SRM
SC Security & Risk Mgmt
Supply Chains in Crisis
Sustainability & Corporate Social Responsibility
Warehousing
All Warehouse Services
Conveyors & Sortation
Lift Trucks & AGVs
Order Management & Fulfillment
Packaging
RFID, Barcode, Mobility & Voice
Warehouse Automation
Warehouse Management Systems
Industries
Aerospace & Defense
Apparel
Automotive
Chemicals & Energy
Consumer Packaged Goods
E-Commerce/Omni-Channel
Food & Beverage
Healthcare
High-Tech/Electronics
Industrial Manufacturing
Pharmaceutical/Biotech
Retail
Think Tank
Pharmaceutical/Biotech: Page 7
Kearney Index Calls ‘Reality Check’ on Reshoring Trend
American manufacturers rushing to bring production back home from Asia? Time for a reality check, according to the latest Reshoring Index from Kearney.
Trump Admin Probe Could Spell New Tariffs on Machinery, Medical Supplies
As part of the probe, the DOC is calling on companies to comment on their projected demand for affected products, and the potential for foreign control or exploitation of related supply chains.
Pharma & Life Sciences Risk & Compliance Conference to take place in October 2025, London
In Pharma and Life Sciences, compliance underpins every link in the global supply chain. Organizations must manage complex partner networks, navigate evolving regulations, and mitigate risk across operations—all while adopting emerging technologies like AI safely and efficiently.
U.K. Pharma Firm Pledges Massive Investment in U.S.
The announcement came at the start of U.S. President Donald Trump's visit to the U.K., as drugmakers face pressure from the Trump administration to move production to the U.S.
U.S. Pharma Giant Kills Planned €1B U.K. Investment
Merck says that it will also clear out its laboratories in the London Bioscience Innovation Centre and the Francis Crick Institute by the end of 2025.
Climate Change Exposes Weak Links in U.S. Medical Supply Chains
As climate change has intensified the risks posed by hurricanes in the Southeast, hospitals and their suppliers will have to prepare for a future of disruptions to their supply chains.
Lutnick Targets Swiss Pharma Giants for Making Money Off America
Lutnick’s remarks come ahead of another meeting between U.S. and Swiss officials after failed trade talks last month resulted in a 39% tariff rate for the European country.
U.S. Tariff Uncertainty Delays the Economic ‘Power’ Lutnick Predicted
The judges let the levies stay in place while the case proceeds, threatening to freeze corporate investment decisions until the cost of tariffs are clearer.
Trump Concedes Lower Tariffs for EU Pharma, Semiconductors
The EU will first have to pass legislation reducing U.S. export tariffs to zero in order to get the 27.5% tariffs on car exports reduced to 15%.
Future-Proofing Pharmaceutical Imports: Tactics for a Volatile 2025
Pharmaceutical importers are navigating one of the most volatile trade environments in recent memory.
In the Age of Supply Chain Tech, Who — or What — Is a ‘Partner’?
By all means, consider embracing technology to supercharge all aspects of your supply chain. But never underestimate the power of human-driven partnerships to yield the best and most valuable results.
Trump Demands U.S. Drug Price Cuts, Sending Pharma Shares Slumping
The pharmaceutical industry has long protested the idea of globally linked drug prices as a threat to years of U.S. dominance in biomedical research.
Previous Page
Page 7 of 336
Next Page
Sign me up!
Receive the latest supply chain trends, news and analysis from SupplyChainBrain.
Email Address
*
Sign Up
Featured Product
Case Studies
Case Studies
How a Leading U.S. Floral Distribution Company Reduced Warehouse Labor Costs by 45% with RFID
Case Studies
Recycled Tagging Fasteners: Small Changes Make a Big Impact
Case Studies
Enhancing High-Value Electronics Shipment Security with Tive's Real-Time Tracking
Case Studies
Moving Robots Site-to-Site